Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Peter F. Thall
Multi-Institutional Study of Post-Transplantation Cyclophosphamide as Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
A Randomized Phase 2 Trial of a Preparative Regimen of Bortezomib, High-Dose Melphalan, Arsenic Trioxide, and Ascorbic Acid
Cancer
Cancer Research
Oncology
Bayesian Regression Analyses of Radiation Modality Effects on Pericardial and Pleural Effusion and Survival in Esophageal Cancer
Radiotherapy and Oncology
Nuclear Medicine
Oncology
Radiology
Hematology
Imaging
Utility-Based Designs for Randomized Comparative Trials With Categorical Outcomes
Statistics in Medicine
Epidemiology
Statistics
Probability
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Adaptive Randomization to Improve Utility-Based Dose-Finding With Bivariate Ordinal Outcomes
Journal of Biopharmaceutical Statistics
Statistics
Probability
Pharmacology
A Possible Association Between Aprotinin and Improved Survival After Radical Surgery for Mesothelioma
Cancer
Cancer Research
Oncology
Practical Model-Based Dose Finding in Early-Phase Clinical Trials: Optimizing Tissue Plasminogen Activator Dose for Treatment of Ischemic Stroke in Children
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Utility-Based Optimization of Combination Therapy Using Ordinal Toxicity and Efficacy in Phase I/Ii Trials
Biometrics
Statistics
Genetics
Probability
Molecular Biology
Biochemistry
Applied Mathematics
Microbiology
Immunology
Biological Sciences
Medicine
Agricultural
